psi unitaid hiv star project
TRANSCRIPT
Stimulating and shaping the market for HIV self‐testing in Africa
UNITAID/PSI HIV STAR Project
Dr Karin Hatzold, Project Director Population Services International
Status and Future for HIVST Meeting BMGF
Seattle , 27th of February 2015
Framework to Catalyze the Market
50% PLHIV unaware of status; limited access to
confidential HTC
High price of HIVST kits; limited
demand; lack of
competition; unsupportive
policies
Establish policy
framework; demonstratedemand & supply; quantify
market size
Lower market barriers achieve intended market effects
Greater coverage of HTC & more
people tested in vulnerable and remote communities
Case for intervention Pathway from market to public health impact
Intended market effects
Increased product availability Product quality improvementPrice reduction Improved product delivery
Barnighausen et al. Health policy and Planning 2011
HIV STAR ProjectIncreased AccessDistribute low cost, quality‐assured productsOptimised for safe scale‐up & effective linkage into care & prevention Both general and key populations
Informed demandDefine the best market strategies and packaging for HIVSTBased on consumer preferences, accuracy, uptake among target groups, and cost‐effectiveness data
Strategic barriersSupport the full integration of HIVST into National policy & algorithmsUnderpinned by WHO recommendations and guidelinesInclusion of HIVST in global HIV planning and projection tools
Structural barriersEncourage market entry and competition Through estimation HIVST market size & growth projectionsSupport a harmonised regional regulatory approval framework
STAR Project Goals1) Develop global normative
HIVST guidelines– Informed by project evaluation– Released by WHO
2) National HTC guidelines and algorithms to accommodate HIVST in all countries by the end of project
3) ≥1 HIVOFT products packaged for HIVST added to approved diagnostics list for donors
4) Price reductions for ≥1 quality assured HIVST product
Country Phase 1 Phase 2
Malawi 172,754 420,466South Africa 0 36,000Zambia 200,478 404,522Zimbabwe 359,190 1,069,810Total 732,422 1,930,798
2.7 million kits in 2 Phases of 2 yearsPhase 2 contingent on resubmission at the end of Year 2
Number of HIV self‐tests distributed
Uptake: first time & repeat‐testingEquitable HTC coverage
Social Harms
User demand & preferences
Value for Money
HIV prevention (VMMC) uptake
Treatment and care uptake
Impact
Research AgendaMalawi
172,754 + 420,466Zimbabwe
359,190 + 1,069,810Zambia
200,478 + 404,522
Diagnostic Accuracy Optimised instructions‐for‐use. Accuracy studies
Qualitative and economic studies: General and Key Populations
I
Impact evaluation of multiple different delivery models• Malawi: 10 intervention and 10 matched control communities• Zimbabwe: randomised trial of 80 intervention‐control areas• Zambia: before‐after HIVST in 30 established outreach sites
All countries will evaluate• Safety, unintended consequences
• Demand for ART and VMMC as well as HTC coverage
Community reporting systems. Long‐term follow‐up with sex workers
Market size, Cost‐effectiveness, Decision / SPECTRUM Modelling
Target Populations Rural & Peri‐urban, Urban communities, sex workers, MSM